Despite reporting positive Phase II results for its lead candidate last year, Vaccinex will soon no longer be a publicly ...

Goldman Sachs has ended its policy requiring IPO clients to have diverse boards, citing a legal ruling that ended a similar initiative at the Nasdaq.

The financial results for Anteris for the year ended December 31, 2024 are reviewed below. All amounts in $ refer to U.S. dollars. In 2024, Net Sales were $2.7 million relating to sales of our tissue ...

Company receives approval for Nasdaq or NYSE listing after Beijing’s pledge to help more mainland companies raise funds.

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed ...

AI cloud provider CoreWeave is going public via an IPO on the Nasdaq stock exchange. The number of shares and the price range ...

China clamps down on small-cap U.S. listings by Chinese issuers; China mandates personal information protection compliance ...

For Israeli tech companies with global ambitions, the choice of public market can shape their growth trajectory.

“As a result of legal developments related to board diversity requirements ... The allure of a Goldman IPO or a Nasdaq listing was enough to get companies to meet diversity benchmarks.

Division of Corporation Finance announced that it has expanded its confidential filing process for certain draft registration statements submitted for nonpublic review. Since 2012, many issuers have ...